What is the recommended management for a target lesion nevus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Target Lesion Nevus

A "target lesion nevus" most likely refers to targetoid hemosiderotic nevus (THN), a benign trauma-induced melanocytic nevus variant that requires observation only, not excision, as the purpuric halo resolves spontaneously within 2-4 weeks. 1

Clinical Recognition

THN presents with distinctive features that help differentiate it from melanoma:

  • Sudden onset of a purpuric (bruise-like) halo surrounding a pre-existing nevus, typically without any apparent trigger 1
  • Occurs predominantly in young females on trauma-prone skin sites 2, 1
  • The central nevus persists while the ecchymotic (bruised) halo ultimately disappears 2
  • No symptoms such as pain, bleeding, or rapid growth that would suggest malignancy 2

Dermoscopic Features

Dermoscopy is a useful non-invasive diagnostic tool that can help avoid unnecessary biopsy 1:

  • Central nevus shows black-brown, globular or homogeneous pattern, possibly with reddish, purple, or black structureless areas and comma-shaped vessels 1
  • Peripheral purpuric halo has two patterns: homogeneous reddish/purplish red areas, or an inner pale zone with outer homogeneous reddish/purplish red zone 1

Management Approach

Conservative observation is the recommended management for THN:

  • No surgical intervention required beyond follow-up observation, as this is a benign lesion 1
  • The purpuric halo resolves spontaneously within 2-4 weeks with rare recurrence 1
  • Biopsy can be avoided when dermoscopic features are characteristic 1

When to Consider Excision

Excision should only be considered if the lesion demonstrates concerning features that suggest malignant transformation rather than THN:

  • Rapid growth of the central nevus itself (not just the halo) 3
  • Bleeding or ulceration not explained by minor trauma 3
  • Development of firm nodules within the lesion 3
  • Persistent color changes beyond the expected resolution timeframe of 2-4 weeks 1
  • Pain or other symptoms that are atypical for benign nevi 3

Histopathologic Findings (If Biopsy Performed)

If excision is performed due to diagnostic uncertainty, expected findings include 2, 1:

  • Intradermal or compound nevus in the central portion
  • Dilated vessels with hobnail characteristics
  • Extravasated erythrocytes (red blood cells outside vessels)
  • Hemosiderin deposits (iron from broken-down blood)
  • Possible perivascular inflammatory infiltration and fibrin deposits

Important Pitfall to Avoid

Do not mistake THN for melanoma based solely on the sudden appearance of pigmentation change 2. The key distinguishing features are:

  • THN has a purpuric (bruise-like) quality to the peripheral halo, not true melanin pigmentation 2, 1
  • The change is abrupt and complete (develops the targetoid appearance suddenly), whereas melanoma typically shows gradual, progressive changes 2
  • The central nevus remains stable in size and characteristics 2

Patient Education

Inform patients that 1:

  • The halo will fade naturally over 2-4 weeks
  • Recurrence is rare
  • No treatment is necessary
  • They should return only if the central nevus itself changes (grows, bleeds, develops nodules)

References

Research

Targetoid haemosiderotic nevus: four cases and a literature review.

European journal of dermatology : EJD, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.